Precision powered performance in total joint hemostasis
Experience the power of the FASTSEAL 6.0 Wand using the WEREWOLF+ Controller - a single unit available to use in orthopaedic procedures. - a single unit available to use in orthopaedic procedures.
We're aiming for a new era of performance and value.
Medical education
Related Products
Disclaimers
*Emissions included toluene, benzene and acrylonitrile; as demonstrated ex vivo at maximum settings, n=6 devices.
**Compared to monopolar electrocautery, demonstrated in total knee arthroplasty. n=123. Acute blood loss - p=0.001; Total blood loss - p=0.04. Lower blood transfusion rate – p=0.04.
***Shorter procedure time demonstrated in infected revision total knee arthroplasty; p=0.044, n=80.
****As demonstrated in vivo at maximum setting in a beef heart soft tissue model. Single device tested 30 times.
Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.
Citations
- Marulanda GA, et al. Expert Rev Med Devices. 2008;5(2):125-131.
- Derman PB, et al. Am J Orthop (Belle Mead NJ). 2013;42(9):407-411.
- Smith+Nephew 2021. Internal Report. 110180-02 Rev A.
- Epstein NJ. Poster presented at: Orthopaedic Research Society (ORS) Annual Meeting; February 7–11, 2025; Phoenix, AZ
- Smith+Nephew 2021. Internal Report. 110154-01 Rev
- Smith+Nephew 2021. Internal Report. 110127-01 Rev A.
- Smith+Nephew 2021. Internal Report. EO.SPM.PCS.037.001.v1.
- Smith+Nephew 2021. Internal Report. 21-0006A-01 Rev A.
- Smith+Nephew 2021. Internal Engineering protocol. 21-0006A Rev A.
- Smith+Nephew 2021. Internal Report. 21-0005-01 Rev A.
Title
Text